01 2Aurobindo Pharma Limited
02 1Cipla Ltd.
03 1Glaxo Wellcome Manufacturing Pte. Ltd
04 2Hetero Labs Limited
05 1LAURUS LABS LIMITED
06 2MYLAN LABORATORIES LIMITED
07 1SMS Pharmaceuticals Limited
08 1Signa S.A. de C.V.
09 2Tianish Laboratories Private Limited
10 1Vijayasri Organics Private Limited
11 1Viyash Life Sciences Private Limited
01 7LAMIVUDINE
02 7Lamivudine
03 1lamivudine
01 11India
02 1Mexico
03 2U.S.A
04 1United Kingdom
NDC Package Code : 65862-259
Start Marketing Date : 2024-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-577
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7538
Start Marketing Date : 2016-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52482-003
Start Marketing Date : 2014-03-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0016
Start Marketing Date : 1995-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-714
Start Marketing Date : 2017-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50787-0027
Start Marketing Date : 2009-07-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67835-0017
Start Marketing Date : 2019-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-756
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-701
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
78
PharmaCompass offers a list of Lamivudine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lamivudine manufacturer or Lamivudine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lamivudine manufacturer or Lamivudine supplier.
PharmaCompass also assists you with knowing the Lamivudine API Price utilized in the formulation of products. Lamivudine API Price is not always fixed or binding as the Lamivudine Price is obtained through a variety of data sources. The Lamivudine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Heptovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Heptovir, including repackagers and relabelers. The FDA regulates Heptovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Heptovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Heptovir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Heptovir supplier is an individual or a company that provides Heptovir active pharmaceutical ingredient (API) or Heptovir finished formulations upon request. The Heptovir suppliers may include Heptovir API manufacturers, exporters, distributors and traders.
click here to find a list of Heptovir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Heptovir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Heptovir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Heptovir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Heptovir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Heptovir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Heptovir suppliers with NDC on PharmaCompass.
We have 11 companies offering Heptovir
Get in contact with the supplier of your choice:
